Search Reports:
  Search
spacer
MORE INFORMATIONarrow
Not sure this is the report that you need? Have questions about the report before purchasing? We're here to help!
HOW TO ORDERarrow
Ordering reports couldn't be easier. Select the license for your needs, click Order Now, and complete our streamlined checkout process. We accept major credit cards, wire/bank transfers, and checks.

MC, Visa, AMEX, Diners, Discovery, JCB
MORE OPTIONSarrow
ABOUT THE PUBLISHERarrow
Life Science Analytics, Inc. (LSA), is a biomedical data company that provides comprehensive pipeline, financial and venture information on more than 13,000 biomedical companies worldwide. Their data and research products serve executives in the pharmaceutical, biotech, and financial industries. LSA products, including MedTRACK and MedTRACK Venture Finance, provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes."

Threshold Pharmaceuticals Inc - Therapeutic Competitors

Published by Life Science Analytics on Apr 14, 2010 - 64 pages
PDF format - Delivered by Email within 1 business day
License Options Question


Report Abstract Table of Contents Companies Mentioned Request Details
Threshold Pharmaceuticals Inc - Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company's products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication.

Scope of the reports

Life Science Analytics' Competitor Reports deliver detailed analysis of a company's preclinical, clinical and marketed pipeline of products.

A complete listing of each company's entire pipeline is provided along with graphical and tabular presentation of the pipeline by therapeutic or disease category.

Every Competitor Report lists a company's individual marketed and pipeline products by disease area, as well as detail on public and private company competitors for each.

An overview of each company's discontinued product line provides insight into product attrition rates.
Life Science Analytics' Competitor Reports provide extensive information including:
  • Company business descriptions
  • Product pipelines by stage of development including discontinued products
  • Therapeutic areas of research
  • Indications treated
  • An extensive list of competitors by disease indication.
Key benefits
  • Competitor Reports provide the user with independent insight into a company's management structure, financial position and products - vital intelligence for investors, competitors and partners.
  • Understand the uniqueness of a company's pipeline by obtaining detail on competitive products in development by other public and private companies - independent information that will enable the user to make informed strategic decisions.
  • Graphical representation of data coupled with detailed listings of all products in development and in production allows the user to quickly assess the depth of a company's pipeline and the strength of the company's product portfolio.






Copyright © 2014 Fast Market Research, Inc.